News: Sandoz Launches Glatopa Copy of Copaxone $NVS

Sandonz has launched the generic substitute of Copaxone naming Glatopa the first FDA-approved, substitute generic version of Copaxone® 20mg.

The drug is used as a treatment for relapsing forms of multiple sclerosis.

Glatopa, developed in collaboration with Momenta and produced entirely in the US.

View the full release here.